UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of Docking in Anticancer Drug Discovery

Letters in drug design & discovery, 2023-01, Vol.20 (10), p.1490-1511

2023

Volltextzugriff (PDF)

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1655-1657

2020

Volltextzugriff (PDF)

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease

Scientific reports, 2024-10, Vol.14 (1), p.24298-18, Article 24298

2024

Volltextzugriff (PDF)

Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations

Hemato, 2024-03, Vol.5 (1), p.26-34

2024

Volltextzugriff (PDF)

Epidemiology and Predictors of Blood Transfusion in Hospitalizations for Sickle Cell Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.3103-3103

2021

Volltextzugriff (PDF)

National Burden of Encapsulated Bacterial Infections in Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.5148-5149

2022

Volltextzugriff (PDF)

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Blood, 2022-11, Vol.140 (Supplement 1), p.694-695

2022

Volltextzugriff (PDF)

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

Blood, 2021-11, Vol.138 (Supplement 1), p.4828-4828

2021

Volltextzugriff (PDF)

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts

American journal of hematology, 2020-02, Vol.95 (2), p.198-204

2020

Volltextzugriff (PDF)

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Blood, 2022-11, Vol.140 (Supplement 1), p.7565-7566

2022

Volltextzugriff (PDF)

Interim Safety and Efficacy Results from a Phase 1/2 Study of Zinc Finger Nuclease-Modified Autologous Hematopoietic Stem Cells for Sickle Cell Disease (PRECIZN-1)

Blood, 2022-11, Vol.140 (Supplement 1), p.4907-4909

2022

Volltextzugriff (PDF)

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Blood, 2021-11, Vol.138 (Supplement 1), p.4879-4879

2021

Volltextzugriff (PDF)

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.4812-4812

2021

Volltextzugriff (PDF)

Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)

Blood, 2021-11, Vol.138 (Supplement 1), p.2930-2930

2021

Volltextzugriff (PDF)

Very long term follow-up of high dose chemotherapy followed by autologous stem cell transplantation in high risk locally advanced triple negative breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13094-e13094

2020

Volltextzugriff (PDF)

Does Use of Biosimilar G-CSF Change Plerixafor Utilization during Stem Cell Mobilization for Autologous Stem Cell Transplant?

Blood, 2018-11, Vol.132 (Supplement 1), p.4557-4557

2018

Volltextzugriff (PDF)

Long-Term Outcomes of Allogeneic Stem Cell Transplant in Peripheral T-Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.4672-4672

2018

Volltextzugriff (PDF)

G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD

Leukemia & lymphoma, 2021-01, Vol.62 (2), p.446-453

2021

Volltextzugriff (PDF)

Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents

Leukemia & lymphoma, 2022-03, Vol.63 (4), p.813-820

2022

Volltextzugriff (PDF)

Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.4527-4527

2019

Volltextzugriff (PDF)

Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Relapse-Free and Overall Survival

Blood, 2019-11, Vol.134 (Supplement_1), p.4488-4488

2019

Volltextzugriff (PDF)

Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival

Blood, 2019-11, Vol.134 (Supplement_1), p.3311-3311

2019

Volltextzugriff (PDF)

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Blood, 2020-11, Vol.136 (Supplement 1), p.19-20

2020

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(83)
Buchkapitel
(2)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(15)
Hematology
(14)
Adult
(11)
Oncology
(10)
Stem Cell Transplantation
(10)
Female
(8)
Male
(8)
Middle Aged
(7)
Transplantation
(7)
Aged
(6)
Hematopoietic Stem Cell Transplantation
(6)
Stem Cells
(6)
Disease-Free Survival
(5)
Graft Vs Host Disease - Etiology
(5)
Graft Vs Host Disease - Prevention & Control
(5)
Retrospective Studies
(5)
Allografts
(4)
Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Role of Docking in Anticancer Drug Discovery

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease

Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations

Epidemiology and Predictors of Blood Transfusion in Hospitalizations for Sickle Cell Disease

National Burden of Encapsulated Bacterial Infections in Sickle Cell Disease

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Interim Safety and Efficacy Results from a Phase 1/2 Study of Zinc Finger Nuclease-Modified Autologous Hematopoietic Stem Cells for Sickle Cell Disease (PRECIZN-1)

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)

Very long term follow-up of high dose chemotherapy followed by autologous stem cell transplantation in high risk locally advanced triple negative breast cancer

Does Use of Biosimilar G-CSF Change Plerixafor Utilization during Stem Cell Mobilization for Autologous Stem Cell Transplant?

Long-Term Outcomes of Allogeneic Stem Cell Transplant in Peripheral T-Cell Lymphoma

G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD

Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents

Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Relapse-Free and Overall Survival

Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Suchergebnisse filtern